Proton Pump Inhibitors Market Share

Market Share of Proton Pump Inhibitors Industry

The proton pump inhibitors market is moderately fragmented, owing to the presence of various players in the market. The market players are focusing on acquiring market shares by focusing on aggressive advertisements and awareness programs among patients. The major key players in the market include AstraZeneca, Bayer AG, Cadila Pharmaceuticals, GlaxoSmithKline PLC, and Pfizer, among others.

Proton Pump Inhibitors (PPIS) Market Leaders

1. Bayer AG

2. Pfizer Inc.

3. Takeda Pharmaceuticals

4. Cadila Pharmaceuticals

5. AstraZeneca

*Disclaimer: Major Players sorted in no particular order